Wang You-Lin, Wu Shuai, Jiang Bo, Yin Fu-Fen, Zheng Shuai-Shuai, Hou Si-Chuan
Department of Urology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China.
Department of Urology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China.
Clin Genitourin Cancer. 2015 Aug;13(4):261-270. doi: 10.1016/j.clgc.2015.01.003. Epub 2015 Jan 24.
Prostate cancer (PCa) remains the most commonly diagnosed malignant tumor in men, and is the second highest cause of cancer mortality after lung tumors in the United States. Accumulating research indicates that microRNAs (miRNAs) are increasingly being implicated in PCa. miRNAs are conserved small noncoding RNAs that control gene expression posttranscriptionally. Recent profiling research suggests that miRNAs are aberrantly expressed in PCa, and these have been implicated in the regulation of apoptosis, cell cycle, epithelial to mesenchymal transition, PCa stem cells, and androgen receptor pathway. All of these might provide the basis for new approaches for PCa. Here, we review current findings regarding miRNA research in PCa to provide a strong basis for future study aimed at promising contributions of miRNA in PCa.
前列腺癌(PCa)仍然是男性中最常被诊断出的恶性肿瘤,在美国是仅次于肺癌的第二大致癌死亡原因。越来越多的研究表明,微小RNA(miRNA)与前列腺癌的关系日益密切。miRNA是保守的小非编码RNA,可在转录后控制基因表达。最近的分析研究表明,miRNA在前列腺癌中异常表达,并且这些miRNA与细胞凋亡、细胞周期、上皮-间质转化、前列腺癌干细胞和雄激素受体途径的调节有关。所有这些都可能为前列腺癌的新治疗方法提供基础。在此,我们综述了目前关于前列腺癌中miRNA研究的发现,为未来旨在研究miRNA在前列腺癌中潜在作用的研究提供有力依据。